Lecture 36 Degenerative Diseases of the CNS Flashcards

1
Q

Common features of neurodegenerative diseases

A
  • Aetiology largely unknown (mendelian genetic cases rare, often younger onset)
  • Usually late onset
  • Gradual progression
  • Neuronal Loss (specific neuropathology)
  • Structural imagine often normal (but there may be atrophy that is not visible)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define Dementia

A

• Progressive impairment of multiple domains of cognitive function in alert patient leading to loss of acquired skills and interference in occupational and social role

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name causes of late onset dementia

A

Alzheimer’s, Vascular, Lewy Body, Others- common causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name causes of young onset of dementia

A

Alzheimer’s, Vascular, Frontotemporal, Alcohol, Huntington’s, HIV, CJD, MS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name treatable causes of dementia

A
  • Vitamin deficiency -B12
  • Endocrine - thyroid disease
  • Infective - HIV, syphilis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name mimics of dementia

A

o Hydrocephalus
o Tumour
o Depression: Pseudodementia (apathetic, slow thinking, confused)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do you diagnose dementia

A

History
Examination
Investigations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What history would you take for diagnosing dementia

A

o Type of deficit
o Progression
o Risk Factors
o FH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What type of examination would you carry out to diagnose dementia

A

o Cognitive function
o Neurological
o Vascular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What investigations would you carry out to investigate dementia

A
o	Routine bloods: B12, Thyroid function
o	CT/MRI- rule out any causes that mimic dementia
o	CSF- MS, CJD
o	EEG
o	Functional imaging
o	Genetics (biopsy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name the various domains involved in the examination of cognitive function

A
  • Memory, attention, language, visuospatial,

* Behaviour, emotion, executive function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is apraxia

A

inability copy certain movements and are unable to, inability to dress- cognitive ability to create a motor plan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is agnosia

A

does not recognizes faces, can’t tell its face- unable to link sensory to cognitive processing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What screening tests can be used to examine cognitive function

A
  • Mini-mental (MMSE)- memory

* Montreal (MOCA)- executive function and memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the commonest neurodegenerative condition

A

Alzheimer’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the risk factors for Alzheimer’s

A
Genetic
Smoking
Exercise
Diet
Alcohol
17
Q

Name features of temporal-parietal dementia

A

– Early memory disturbance
– Language and visuospatial problems
– Personality preserved until later

18
Q

Name the features of Fronts-temporal dementia

A
  • Early change in personality / behavior
  • Often change in eating habits
  • Early dysphasia
  • Memory / visuospatial relatively preserved
19
Q

Name features of Vascular dementia

A

Mixed picture

Stepwise decline

20
Q

Non-pharmacological treatment of Alzheimer’s

A

– Information & support, dementia services
– Occupational therapy
– Social work / support / respite / placement
– Voluntary organisations

21
Q

Specific treatment for Alzheimer’s

A

– Cholinesterase inhibitors (cholinergic deficit)
– NMDA antagonist (memantine)
No treatment for fronto-temporal
Decrease vascular risk factors for vascular dementia

22
Q

What are the clinical features of Parkinson’s

A

– Bradykinesia (slowness of movement)
– Rigidity (stiffness)
– Tremor (shakiness)
– Postural instability (unsteadiness / falls)

23
Q

What is the pathology of the basal ganglia in Parkinson’s

A

Predominantly dopamine loss

24
Q

What are the causes of Parkinson’s

A
Dopamine antagonists
Vascular parkinsons
Dementia with Lewy bodies 
Multiple system atrophy
Progressive supra nuclear palsy
25
Q

How is Parkinson’s Diagnosed

A
  • Bradykinesia + ≥1 tremor, rigidity, postural instability
  • No other cause / atypical features
  • Slowly progressive (> 5-10 yrs)
26
Q

Name the early treatment for Parkinson’s diseases

A
  • Levodopa
  • Metabolised by liver so given with COMT enzyme inhibitor
  • MAO-B inhibitor- dopamine recycling
  • Dopamine agonists
27
Q

Name the Late treatment for Parkinson’s Disease

A
  • Prolong levodopa half-life:
  • MAO-B inhibitors
  • COMT inhibitor
  • slow release levodopa
  • Add oral dopamine agonist
  • Continuous infusion (apomorphine, Duodopa)
  • Functional neurosurgery (deep brain stimulation)
  • Allied health professionals +/- care package
28
Q

Wha are the drug induced complications of Parkinson’s treatment

A

o Motor fluctuations - levodopa wears off
o Dyskinesias - involuntary movements (levodopa)
o Psychiatric - hallucinations, impulse control- overproduction of dopamine

29
Q

What are the non-drug induced

A
o	Depression (20%) 
o	Dementia (~50% after 10 yrs) 
o	Autonomic:  BP, bladder, bowel
o	Speech, swallow
o	Balance